todays news shows management are going to try and keep dilution at a minimum and are confident that sp will be a lot higher in coming months, years ....
lots of work already done, more to come .... hopefully they can start selling their recurring revenue model to serious investors and get some forward momentum. in this environment, a growth company reaping govt health dollars in china, india and middle east has huge potential. what was that award they won a few years back ??? ''the next big thing''
god knows they've made us wait.
lol
Add to My Watchlist
What is My Watchlist?